Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q1 2024 (March 31)4holders
1famous investor
$0.77avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings. The largest holders were Armistice Capital, LLC ($156K), Clear Street LLC ($39K) and Citadel Advisors ($19K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 4 holders
| Armistice Capital, LLC | — | No change | 204,082 | $156K |
| Clear Street LLC | — | Add +98.9% | 50,512 | $39K |
| Citadel Advisors | — | Reduce -0.8% | 24,180 | $19K |
| Warberg Asset Management LLC | — | Reduce -31.6% | 15,679 | $12K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.